Retrospective Study
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Feb 27, 2023; 15(2): 211-221
Published online Feb 27, 2023. doi: 10.4240/wjgs.v15.i2.211
Table 1 Clinical characteristics of patients and three immune-nutritional score systems
CharacteristicsImmune–nutritional score systems
Values (n = 54)
PNI (n = 27/27)
P value
CONUT (n = 34/20)
P value
NPS (n = 32/22)
P value
Age (years)1.0000.3680.047
< 702613/1318/819/7
≥ 702814/1416/1213/15
Gender1.0000.7130.216
Male4221/2127/1523/19
Female126/67/59/3
Primary tumor size0.7900.5811.000
≤ 3 cm2713/1418/916/11
> 3 cm2714/1316/1116/11
Gross type0.4120.3130.386
Non-ulcerative type2112/915/614/7
Ulcerative type3315/1819/1418/15
Differentiation0.2850.4490.189
Well/Moderate2816/1219/919/9
Poor2611/1515/1113/13
T stage0.5880.5190.984
T1/T22212/1015/713/9
T3/T43215/1719/1319/13
Lymph node metastasis0.1060.4490.445
No2817/1119/918/10
Yes2610/1615/1114/12
cTNM status0.2820.5380.075
I/II3017/1320/1021/9
III2410/1414/1011/13
Table 2 Cox regression analysis of overall survival
CharacteristicOS
HR
95%CI
P value
Age (years)0.500
< 701.0000.605-2.796
≥ 701.301
Gender0.451
Male1.0000.261-1.1.816
Female0.689
Primary tumor size0.926
≤ 3 cm1.0000.479-2.242
> 3 cm1.037
Gross type0.014
Non-ulcerative type1.0001.285-8.932
Ulcerative type3.388
Differentiation0.032
Well/Moderate1.0001.083-5.629
Poor2.469
T stage0.289
T1/T21.0000.671-3.823
T3/T41.601
Lymph node metastasis<0.001
No1.0001.963-10.472
Yes4.534
cTNM stage0.001
I/II1.0001.734-9.117
III3.976
PNI group0.002
Low risk1.0001.724-10.030
High risk4.158
CONUT group0.039
Low risk1.0001.041-4.666
High risk2.204
NPS group< 0.001
Low risk1.0001.879-9.425
High risk4.208